Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Peripheral Sphingolipids as Potential Biomarkers of Parkinson disease Including Sex-Related Differences

Author:Ortega, Roberto   Burbulla, Lena   Mileva, Izolda   Taylor, Graeme   Cuperlovic-Culf, Miroslava   Glickman, Amanda   Pullman, Mariel   Scherzer, Clemens   Raymond, Deborah   Miltenyi-Miltenberger, Gabriel   Yoo, Andrea   Nichols, William   Krainc, Dimitri   Bressman, Susan   Obeid, Lina   Hannun, Yusuf   Bennett, Steffany   Saunders-Pullman, Rachel   

Session Name:P3: Movement Disorders: Biomarkers and Genetics of Parkinson's Disease 1  

Topic:Movement Disorders  

Program Number:P3.007  

Author Institution:Mount Sinai, New York, NY  Northwestern University Feinberg School of Medicine , Chicago, IL  The State University of New York at Stony Brook, Stony Brook, NY  University of Ottawa, Ottawa, ON, Canada  University of Ottawa, Ottawa, ON  UC Denver, Aurora, CO  Brigham and Women'S Hospital/Harvard Medical School, Boston, MA  Beth Isreal Medical Center, New York, NY  University of Lisbon, Lisbon, Portugal  Mount Sina Beth Israel, New York, NY  Cincinnati Children's Hospital Medical Center, Cincinnati, OH  Northwestern University, Chicago, IL  Mount Sinai Health System, New York, NY  Stony Brook, Stony Brook, NY  Mount Sinai Beth Israel, Neurology, Downtown Union Square, New York, NY  

Access to health care in patients with epilepsy in Latin America

Author:Villegas, Ana   Lemus, Hernan Nicolas   Mayor-Romero, Luis Carlos   Martinez, Paula   

Session Name:P4: Global Health  

Topic:Global Health  

Program Number:P4.014  

Author Institution:Universidad El Bosque, Bogota, Colombia  Brigham and Women's Hospital, Boston, MA  Fundacion Santa Fe de Bogota, Bogota, Colombia  

Effect of endocrine disrupting chemicals on early disease course in Multiple sclerosis

Author:Chuang, Tzu-ying   Feldman, Talia   Healy, Brian   Saxena, Shrishti   Sanon, Eunnindy   Saraceno, Taylor   Chitnis, Tanuja   

Session Name:P5: MS Prognosis/Epidemiology  

Topic:MS and Inflammatory Disease  

Program Number:P5.004  

Author Institution:Brigham and Women's Hospital, Boston, MA  

Cognitive Processing Speed Predicts Disability Milestones in Multiple Sclerosis

Author:Howard, Danielle   Lokhande, Hrishikesh   Healy, Brian   De Las Heras, Virginia   Arnould, Sophie   Glanz, Bonnie   Zurawski, Jonathan   Polgar-Turcsanyi, Mariann   Saraceno, Taylor   Weiner, Howard   Chitnis, Tanuja   

Session Name:P5: MS Prognosis/Epidemiology  

Topic:MS and Inflammatory Disease  

Program Number:P5.014  

Author Institution:Brigham and Women's Hospital, Boston, MA  Novartis Pharma AG, Basel, Switzerland  

Intranasal Delivery of TGFa – A Novel Therapeutic Approach for Lesion Resolution in Multiple Sclerosis?

Author:Loesslein, Lena   Linnerbauer, Mathias   Tsaktanis, Thanos   Quintana, Francisco   Rothhammer, Veit   

Session Name:P7: MS Therapeutics 1  

Topic:MS and Inflammatory Disease  

Program Number:P7.001  

Author Institution:University Hospital Erlangen, Erlangen, Germany  Brigham and Women's Hospital/Harvard Medical, Boston, MA  Universität Erlangen-Nuernberg, Erlangen, Germany